Charité Cyberknife Center

At the Charité is one of 11 cyberknife centers in Germany. It is the first one at a university hospital.

Since 2011, patients have been successfully treated in close cooperation between radiotherapists and neurosurgeons.

Direct advice: (Mo - Fr 08:00 bis 14:00 Uhr)

+49 30 450 557 221

You are here:

The Charité Cyberknife Center...

... is a cooperation project of the Department of Radiation Oncology and Radiation Therapy under the direction of Prof. Dr. med. Budach and the Department of Neurosurgery under the direction of Prof. Dr. med. Vajkoczy. The radiotherapeutic and neurosurgical expertise of the two clinics is bundled in the Cyberknife Center.

At the Department of Radiation Oncology and Radiotherapy Charité Berlin complements the state-of-the-art Cyberknife radiation treatment under the coordination of Dr. med. Senger the treatment spectrum for intra- and extracranial tumor treatments.

What distinguishes us?

  • the entire portfolio of radiotherapy and neurosurgery is available
  • Indication examination in the interdisciplinary tumor board
  • high quality of treatment through personal care and expertise
  • personal communication between the treatment team and referring physicians

What is Cyberknife?

The Cyberknife is a robot-based system for precision irradiation. With submillimeter accuracy, high doses of radiation can be concentrated in the tumor, thus sparing adjacent healthy tissue.

Similar to a scalpel in surgery - hence the name "Cyberknife" - the target structure is switched off while protecting the surrounding tissue. The beams used correspond to high-energy X-rays (6 MeV photons), which are also used in conventional radiotherapy.

A software-controlled image-tracking system handles the automatic positioning of the patient, which can be corrected via a robot-guided treatment table.

The Cyberknife can predict the movements of the patient or certain organs (eg lungs) in the treatment thanks to the dynamic positioning.

Benefits of Cyberknife Treatment

The precision of the system allows the irradiation of the treatment dose in a single session. If necessary, the radiation dose can be divided into three to five treatment sessions. In particular, in sensitive areas of the body optimal protection of the surrounding, healthy tissue is achieved.

Particular advantages arise in the treatment of tumors in organs that move through the breathing. The respiratory movements can be recorded and balanced at the same time.

Since the treatment itself is painless, it can be performed on an outpatient basis. Overall, cyberknife treatment does not affect the quality of life. As a rule, the patient can return to his usual routine shortly after treatment.

Advantages at a glance:

  • Outpatient instead of inpatient treatment
  • non-invasive and painless treatment
  • no fixation in a fixed frame
  • Alternative to open surgery
  • Alternative to conventionally fractionated radiotherapy
  • no narcosis or sedation
  • no increased risk due to age or comorbidities